Illustration of a clinic building (not a photo of Dana-Farber Cancer Institute, Inc.)
Illustration

Daniel J. Deangelo, MD

Medical Oncology in Boston, MA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 33 years since graduation
  • Public record — not managed by the clinician

About Dr. Daniel Deangelo

Dr. Daniel Deangelo is a physician specializing in medical oncology practicing in Boston, MA, a graduate of Albert Einstein College of Medicine of Yeshiva University (1993). Records list 3 practice addresses. Affiliated with Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital and 1 more. Treated 251 Medicare patients in 2024.

Provider details

SpecialtyMedical OncologyOther medical oncology doctors in Boston
Also practicesHematology/oncology
CredentialsMD
EducationAlbert Einstein College of Medicine of Yeshiva University, 1993CMS Doctors and Clinicians
GenderMale
NPI number1134104920National Provider Identifier (CMS NPPES), issued December 2005
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Daniel Deangelo's specialties and state licenses

  • Hematology & Oncology Primary
    License: MA 81332

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Daniel Deangelo practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Daniel Deangelo

  • Brigham and Women's HospitalHospital · Boston, MA
  • Dana-Farber Cancer InstituteHospital · Boston, MA
  • Massachusetts General HospitalHospital · Boston, MA
  • Mass General Brigham Home Care, IncHome health agency · Newton, MA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Daniel Deangelo's Medicare quality score (MIPS 2024)

84.1/100final MIPS score
65quality
100promoting interoperability
40improvement activities
69.1cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Daniel Deangelo's Medicare patients and services (2024)

251Medicare patients
728services billed
75average patient age
42%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more298$102.02
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes196$82.11
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more88$69.20
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more40$190.53
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more31$151.32
Telephone medical discussion with physician, 21-30 minutes25$101.97
Hospital discharge day management, more than 30 minutes15$120.15

Common conditions among these patients

  • High cholesterol73%
  • High blood pressure69%
  • Arthritis50%
  • Chronic kidney disease35%
  • Ischemic heart disease32%
  • Anxiety disorders26%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Daniel Deangelo (2025)

$37,394.82 in 20 general payments reported in 2025, plus $3,047.10 in research payments.

TypePaymentsAmount
Consulting fees9$24,850
Compensation for services other than consulting3$11,875.22
Travel and lodging2$443.63
Food and beverage6$225.97

Paying companies: Autolus Inc ($6,635.22), AstraZeneca Pharmaceuticals LP ($5,814.41), Pfizer Inc. ($5,240), Geron Corporation ($3,490.99), NOVARTIS PHARMACEUTICALS CORPORATION ($3,400), Sobi, Inc ($2,775).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Dana-Farber Cancer Institute, Inc.

Questions about Dr. Daniel Deangelo

What kind of clinician is Dr. Daniel Deangelo?

Dr. Daniel Deangelo is listed as a physician specializing in medical oncology, also practicing hematology/oncology.

Where does Dr. Daniel Deangelo practice?

Dana-Farber Cancer Institute, Inc. at 450 Brookline Ave, Boston, MA 02215, and 2 other addresses in the records.

What is the office phone number for Dr. Daniel Deangelo?

The listed office number is (617) 632-3000. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Daniel Deangelo?

The National Provider Identifier is 1134104920.

Does Dr. Daniel Deangelo accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Daniel Deangelo affiliated with?

Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, Mass General Brigham Home Care, Inc.

Where did Dr. Daniel Deangelo go to medical school?

Albert Einstein College of Medicine of Yeshiva University, graduating in 1993.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2007-07-08
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Dana-Farber Cancer Institute, Inc. at (617) 632-3000 or visit the clinic page to check availability.

Call now
0 clinics selected Compare